Overview

Tau PET Imaging in Atypical Dementias

Status:
Recruiting

Trial end date:
2023-02-01

Target enrollment:

Participant gender:

Summary

The goal of this study is to demonstrate the feasibility of mapping tau pathology in subjects with Primary Progressive Aphasia, using PET protocol with F-AV-1451 (trade name AV-1451) and to systematically document the extent and location of tau pathology in PPA patients in vivo using the same techniques.

Phase:

Phase 1

Details

Lead Sponsor:

Northwestern University

Collaborator:

National Institute on Aging (NIA)